Alliance Care Technologies is proud to be the international representative for Cure Metrix. We are driving to improve breast cancer detection accurance throuhghmaking AI mammography assessment universally available globally. 

Committed to the advancement of AI technology that will improve cancer survival rates worldwide.
 

Cloud-based, SaaS platform to deliver AI directly to radiologists at the point of diagnosis.

27%  Increase in cancer detection 
(without increase in false-positive recalls)
 

25% Potential recall reduction

 

69% Reduction in False Positives

 

30% reduction in reading time
(for worklist prioritization)


62% Potential reduction in radiologist workload
(without harming sensitivity)

The cmEdge™ application is software that can be installed on an existing hospital or clinic machine.

cmEdge™ anonymizes and encrypts images before directing them to the Cure Matrix Cloud Platform for processing by cmAssist and cmTriage. Process images are returned as a DICOM Structured Report (SR). cmEdge™ application de-anonymizes identifying fields. The cmEdge™ application returns the DICOM SR back to the hospital PACS via a STORESCU request.

cmAssist™ is software intended to identify, mark, and score regions of interest on Full Field Digital

Mammography (FFDM) screening and nonstandard views and bring these regions to the attention of

the radiologist after the initial reading has been completed. cmAssist also provides a quantified

indication of the level of suspicion for each region of interest to assist the radiologist as a decision

support tool with clinical determination.

cmAssist™ is software intended to identify, mark, and score regions of interest on Full Field Digital

Mammography (FFDM) screening and nonstandard views and bring these regions to the attention of

the radiologist after the initial reading has been completed. cmAssist also provides a quantified

indication of the level of suspicion for each region of interest to assist the radiologist as a decision

support tool with clinical determination.

cmTriage™ AI helps the radiologist triage the work list, sort, and prioritize cases by identifying suspicious cases. Based on the preference of the practice, information can then be used to prioritize on the most suspicious cases first or place more experienced radiologist on those cases.  It can also be used to defer less suspicious cases to less experienced radiologists.

*Disclaimer: cmTriage™ is FDA-cleared for commercial use. cmAssist® and cmAngio™ are proprietary and investigational and are not yet available for commercial use.

REDUCE RECALL RATES

Results from preliminary studies across thousands of images suggest that our algorithm can reduce false positive rates that may lead to unnecessary follow-up procedures and undue anxiety among patients.

 

INCREASE EARLY DETECTION

We are developing powerful technology that could enable health care providers to hone in on even the most microscopic changes more quickly and accurately than ever before.

 

IMPROVE EVALUATION OF DENSE BREAST TISSUE

We are designing our image analysis platform to improve the evaluation of dense breasts using mammography.

 

TRACK TREATMENT RESPONSE OVER TIME

Our algorithm has the potential to help physicians track the rate of change of growth of lesions over time, which may enable more informed follow-up and treatment decisions.

 

IMPROVE CLINICAL EFFICIENCY

We seek to develop technology that will identify and classify the most suspicious anomalies and discard the likely benign ones, which may help radiologists improve their triage process and focus where it matters most.

 

SCALE UP TO ADDRESS OTHER CANCERS AND BEYOND

The CureMetrix image analysis platform is the foundation that, when successful, will allow us to extend our technology across modality, anatomy and disease states.

US: +1.443.531.6700

UAE: +971.4.288.8137

Value@AllianceCareTech.com

  • White LinkedIn Icon
  • White Twitter Icon
  • White Facebook Icon
  • White YouTube Icon

© 2020 by Alliance Care Technologies